Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Clinical trial NCT06906341 · RECRUITING

Trial details

NCT number: NCT06906341
Sponsor: Corcept Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Cancer Peritoneal Neoplasms Endometrial Cancer

Start date: 2025-04-11
Primary completion: 2026-08-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.